SPONSOR
Broad Institute of MIT and Harvard
Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Prion Disease
Broad Institute of MIT and Harvard is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Prion Disease.
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Broad Institute of MIT and Harvard
How many clinical trials has Broad Institute of MIT and Harvard sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Broad Institute of MIT and Harvard, of which 1 are actively recruiting participants. These trials cover conditions including Prion Disease. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Broad Institute of MIT and Harvard research focus on?
Broad Institute of MIT and Harvard clinical trials span Prion Disease. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Broad Institute of MIT and Harvard clinical trial?
To participate in a Broad Institute of MIT and Harvard trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Broad Institute of MIT and Harvard trials with current recruitment status updated daily.
Clinical Trials by Broad Institute of MIT and Harvard
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology